Medically reviewed by Qin Rao, MD Diarrhea and constipation are common causes of fecal incontinence.  Dietary changes and medications can help improve fecal incontinence.Eating smaller meals and going ...

Older women who consumed a proinflammatory diet had a greater risk of fecal incontinence, prospective data from the Nurses' Health Study found. In analyses that adjusted for dietary fiber and other ...

Antegrade continence enema (ACE) procedures have emerged as a robust solution for managing faecal incontinence, particularly in patients with refractory conditions such as anorectal malformations, ...

Published in Diseases of the Colon & Rectum, the peer-reviewed study found clinically meaningful symptom reduction, high user engagement, and significant pelvic floor improvements in a real-world ...

IRVINE, Calif.--(BUSINESS WIRE)-- Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company that has developed and is commercializing novel implantable sacral neuromodulation ...

Fecal incontinence (FI), or involuntary loss of bowel control, significantly impacts quality of life and mental health for millions of adults in the U.S. Obesity is thought to affect bowel function, ...

The FDA has expanded the use of Renovia’s digital training approach to treating incontinence among women, greenlighting the program as a first-line, home-based option for people with chronic fecal ...

Although bowel incontinence is more likely to occur due to the above reasons, it can also occur due to tumors in or near the colon, rectum, or anus. If a person experiences frequent or severe bowel ...

Fecal incontinence results when the pressure in the rectum exceeds anal sphincter pressure. Coughing or lifting can transiently increase intra-abdominal pressure and result in stool leakage if the ...

Passive incontinence – refers to the involuntary discharge of stool or gas without awareness; Urge incontinence – refers to the discharge of fecal matter in spite of active attempts to retain bowel ...

Relationship between ERCC1 C8092A and Mad1 G558A polymorphism with disease progression, and survival in patients with advanced epithelial ovarian cancer treated with induction chemotherapy with ...